Introduction: Neurogenic bowel dysfunction resulting from spinal cord injury (SCI) frequently requires bowel care (BC) with stimulant suppositories for initiation of eective defecation. The excessive time required for BC and bowel complications have limited quality of life after SCI. Objective: To test the hypothesis that: the time required for bowel care with bisacodyl suppositories can be reduced by substituting a polyethylene glycol base (PGB) for the traditional hydrogenated vegetable oil base (HVB) in the suppository. Setting: Inpatient SCI medicine unit. Subjects: Fourteen persons with SCI with chronic stable paralysis from upper motor neuron SCI for greater than one year with a stable HVB bisacodyl suppository initiated BC. Design: Crossover Controlled. Method: Subjects received HVB bisacodyl suppositories for six sequential BC sessions and then were crossed over to PGB bisacodyl suppositories for six more BCs. Outcome measures: BC event times were utilized to derive BC intervals: suppository insertion to ®rst¯atus=Time to¯atus, ®rst¯atus until the beginning of stool¯ow=Flatus to stool¯ow, begin stool¯ow until end stool¯ow=Defecation period, end stool¯ow until end of clean up=Clean up, and suppository insertion until end clean up=Total bowel care time. Results: The data included two groups of BC sessions: HVB (n=84) and PGB (n=81). Mean times in minutes and P values from t tests for paired samples yielded: Time to¯atus: (HVB 31, PGB 12.8 P50.002), Defecation period: (HVB 58, PGB 32, P50.0005), Clean up: (HVB 1.9, PGB 3.2 P=0.165), Total bowel care time: (HVB 102, PGB 51.2 P50.0005). Conclusion: This analysis suggests that PGB based bisacodyl suppositories may stimulate re¯ex defecation sooner and shorten the Total BC Time as compared with HVB bisacodyl suppositories.
Introduction
Spinal cord injuries (SCI) result in upper or lower motor neuron damage that frequently produces neurogenic bowel dysfunction. Both the upper motor neuron (UMN) and lower motor neuron (LMN) patterns of bowel dysfunction are characterized by fecal retention and uniformly require a comprehensive plan of management (bowel program) that consists of diet, oral medications and a scheduled evacuation procedure (bowel care) to avoid impaction and incontinence. 1, 2 Classically, bowel care has been a time consuming process that has been detrimental to quality of life. 3 Many people with SCI rank neurogenic bowel dysfunction as a major life limiting problem. 4 ± 7 Bowel care regimens can last longer than 3 h and still produce insucient results. 8 Consequently, in spite of tedious and exacting bowel care regimens, serious problems with bowel evacuation are still reported from as many as 20% of people with SCI. 4, 6 Suppositories containing an active laxative ingredient dispersed in a base substance, are frequently the mode of presentation for the stimulus of the chemical defection re¯ex. Bisacodyl is an active ingredient in many rectal chemical stimulant preparations for defecation. This compound, a diphenylmethane derivative (bis (p-acetoxyphenyl)-2-pyridylmethane) which was ®rst introduced for use as a laxative in 1953 due to its structural similarity to phenolphthalein. Bisacodyl which acts as a contact laxative is practically insoluble in water and sparingly soluble in alcohol. Given rectally in a water suspension it is dispersed along the colonic mucosa. The colonic response can be detected with mucosal electromyography. Bisacodyl then acts within as little as 3 min to suppress rhythmic stationary spike wave activity and increase spasmodic propulsive peristaltic spike activity. 9 Thereafter, re¯ex defecation ensues. Bisacodyl can be administered in many preparations including suppositories, enemas, mini enemas, and solutions. 1, 10 For independent bowel care after SCI typically, 10 mg suppositories are used due to ease of insertion with dexterity de®cits and improved anal retention without voluntary external anal sphincter constriction. The most common suppository preparation includes bisacodyl powder dispersed within a hydrogenated vegetable oil base (HVB). 10 Anecdotal reports suggest bisacodyl suppositories with a vegetable oil base often require a prolonged period to produce defecation and can cause continued mucosal irritation with resultant mucus accidents hours after bowel care is completed. As a result, water-miscible suppositories have been introduced. We have evaluated the eect of polyethylene glycol polymer based (PGB) bisacodyl suppositories using a single subject design. 11 We found that defecation was initiated more rapidly with a resultant signi®cant shortening of the total bowel care time.
This study was carried out to compare the eectiveness of hydrogenated vegetable oil based and polyethylene glycol based bisacodyl suppositories in triggering and producing re¯ex defecation in a cohort of SCI subjects during bowel care administered within a hospital setting.
Methods
Recruitment focused on inpatient SCI persons at the Tampa Veterans Aairs Medical Center SCI unit. Subjects were invited to enter the evaluation if they had been SCI for greater than 1 year, had an upper motor neuron lesion, and used HVB bisacodyl suppositories in a regular, stable bowel care regimen. Subjects were excluded if there was a recent history of constipation, diarrhoea, or medication that could adversely aect bowel function. Baseline demographic information on each subject included: age, years since SCI, SCI level, bulbocavernous re¯ex, anocutaneous re¯ex, anal tone, and phasic re¯exes of the lower extremities. 1 The two types of bisacodyl suppositories used in the study diered only in the base used for dispersion of the active ingredient. The HVB suppositories utilized contained 10 mg bisacodyl USP in a hydrogenated vegetable oil base (UDL Lab, Rockford, USA). The PGB suppositories (Concepts in Con®dence, Islandia, NY, USA) contained 10 mg bisacodyl dissolved in a mixed polyethylene glycol polymer base of two molecular weights: E1450 and E400.
Subjects received one HVB suppository for six sequential regularly scheduled bowel care procedures followed by one PGB per rectum for the following six BC sessions. Each bowel care procedure was performed by a sta nurse with the consistent technique and data collection. 1 All subjects were positioned side-lying with the left side down and knees¯exed. At the beginning of each bowel care session, either a PGB or a HVB bisacodyl suppository was inserted and positioned against the mucosal surface of the rectum at a ®nger length from the anus.
The presence or absence of stool in the rectal vault was recorded. The time of insertion was considered time zero and the progress of bowel care was documented with time parameters (Figure 1 ).
11
Bowel care events were used to separate the total bowel care time period into discrete intervals recorded in minutes: First¯atus (ends the interval from suppository insertion until the ®rst gas is passed), Begin stool¯ow (marks the beginning of the defecation interval), End stool¯ow (marks the end of defecation interval), and Wait until transfer (marks the end of the period of waiting after stool¯ow has ended, the subjective end of the bowel care). 1, 11 For the purpose of this study bowel care was deemed complete at the end of the perianal clean up (End clean up) after waiting to see that no further stool was expelled. Our subjects had bowel care in bed and did not Digital stimulations were carried out in a circular motion with the gloved lubricated index ®nger in an attempt to dilate the external and internal anal sphincters and the distal rectum stimulating re¯ex peristalsis.
1 Digital stimulations were done if stool ow stopped or slowed during the evacuation process (approximately one every 10 min). Digital examination of the rectal vault followed the end of stool¯ow to assure complete evacuation. The number of digital stimulations required for each bowel care session was recorded.
The amount of stool produced with each bowel care session was recorded using the following ordinal scale based on a comparison to the subject's previous bowel care results before the study: (0) no stool, expelled; (1) small-less than expected; (2) moderatestool volume as expected or (3) large-larger than expected results. The time, amount and frequency of mucus and stool accidents were recorded if they occurred between bowel care sessions. Bowel incontinence was de®ned as each individual episode of unplanned stool evacuation that occurred between the end of clean up marking the end of bowel care and the insertion of the suppository for the next bowel care regimen.
Statistical analysis
Mean interval durations for the collective trials with each suppository for each subject were calculated and analysed with t-tests for paired samples using the Statistics Program for the Social Sciences for Windows (SPSS for Windows).
Results

Subject demographics
The 14 subjects were all male and included four incomplete and ten with complete spinal cord injuries. The average age was 53.4 years and the average years since SCI was 18.3. SCI levels ranged from C3 to L1. The bulbocavernosis re¯ex was present in 14/14 and the anal cutaneous re¯ex was present in 9/14. Anal tone was high in 2/14, normal in 3/14 and reduced in 9/ 14.
Bowel care intervals
The means and P values were as follows: Time to¯atus (Suppository insertion until ®rst gas expulsion) HVB=31 min, PGB=12 min P50.002. Defecation period (period of stool¯ow) HVB=58 min, PGB=32 min P50.0005, Clean up (end of stool¯ow to end of clean up)=HVB=1.9 min, PGB=3.2 min P=0.165 (Figure 2 ). The means of the Total bowel care time (suppository insertion until the end of clean up) was HVB=102 min and PGB=51.2 min, P50.0005, a statistically signi®cant dierence. Means of the Total bowel care time for individual subjects were consistently lower with the PGB suppository, (Figure 3 ).
Digital stimulations and stool results
The numbers of digital stimulations required for the bowel care (BC) sessions were averaged (HVB 5.0, PGB 3.2) and compared using t-tests for paired samples P50.0005. The amount of stool produced by the BC was compared for HVB and PGB, and revealed no signi®cant dierence P=0.3505. Sixteen stool incontinence episodes were recorded between BC sessions: 15 after HVB and 1 after PGB.
Discussion
This open label clinical trial investigated the statistical and clinical signi®cance of the use of polyethylene glycol based (PGB) bisacodyl suppositories versus the use of vegetable oil based (HVB) bisacodyl suppositories using a sequential presentation of each agent. We found comparable bowel care eectiveness for the amount of stool eliminated with a reduction in bowel care time by approximately half using the PGB. These time dierences were observed with similar volumes of stool results for bowel care sessions. This improvement in eciency demonstrates a statistically and clinically signi®cant result for these subjects.
The mean bowel care interval that was most reduced was Time to¯atus. We have previously Figure 2 The time intervals of the bowel care periods from all 14 subjects studied were averaged and presented in minutes for PBG (polyethylene glycol based) and HVB (hydrogenated vegetable oil based) bisacodyl suppositories. The Time to¯atus was signi®cantly longer after HVB suppository insertion. The Flatus to stool¯ow period showed no signi®cant dierence between the agents. The Defecation period was signi®cantly shorter with use of the PGB suppository suggested that this time dierence may be due to the rate and amount of bioavailability of the active ingredient (bisacodyl) in the suppositories. 11 Parrott also found polyethylene glycol to be a superior suppository base that facilitated rapid absorption of salicylate. 12 When polyethylene glycol liqui®es in response to body heat it may dissolve and disperse bisacodyl more eectively on mucous membranes.
We also observed a reduction in the time of the defecation or stool¯ow period with PGB. This may be due to a more widespread dispersion of the PGB base with bisacodyl producing a stronger and more sustained re¯ex stool propulsion. We conclude that the simple substitution of a PGB bisacodyl suppository for a HVB one can reduce bowel care time by almost one half. In our study group this saved up to 1 h per BC session for the average patient, improving quality of life.
Bowel care with HVB included more digital stimulations than with PGB. Our protocol required digital stimulations approximately every 10 min to optimize eciency of evacuation. In spite of chemical and mechanical stimulation the average defecation period of the HVB initiated bowel care (58 min) was signi®cantly longer than with PGB (32 min). As a result, more digital stimulations were required during the defecation period with HVB. Although some persons utilize chemically stimulated bowel care routines that do not include digital stimulation, we postulate that chemical and mechanical stimulation complement one another in promoting ecient stool elimination. Our study was designed with the manipulation of only one variable (bisacodyl suppository) and therefore cannot fully evaluate the effectiveness of digital stimulation.
The frequency of unplanned stool evacuations between bowel care sessions was much higher following BC with HVB bisacodyl suppositories. The hydrophobic vegetable oil base (HVB) may sequester the bisacodyl and gradually release it to diuse onto the colon mucosae. This may produce a prolonged stimulus to defecation and an irritation that produces excess mucus secretion in some subjects. The clinician should sensitively inquire about involuntary evacuations experienced by patients and be aware that rectal stimulants may be associated with these events. Alternatives for redesign of the bowel care regimen to improve continence could include use of half of a suppository, consideration of other rectal stimulants (PGB bisacodyl suppositories, therevac mini enemas, glycerine suppositories) or transition to bowel care initiated and sustained by repeated digital rectal stimulation.
1 Reduction in total bowel care time and frequency of incontinence should be foci of intervention in the establishment and re®nement of the bowel program as these parameters have been signi®cantly associated with emotional upset in coping with neurogenic bowel after SCI. 4 The management of neurogenic bowel dysfunction has been recently reviewed in an evidence based clinical guideline. 
